[1]顾冬雪 张雪云 柳立岩.肺癌合并2型糖尿病患者的临床特点分析[J].中国实用乡村医生杂志,2019,26(11):42-44.[doi:10.3969/j.issn.1672-7185.2019.11.019 ]
 GU Dongxue,ZHANG Xueyun,LIU Liyan.Clinical Characteristics of Lung Cancer with Type 2 Diabetes Mellitus[J].Chinese Practical Journal of Rural Doctor,2019,26(11):42-44.[doi:10.3969/j.issn.1672-7185.2019.11.019 ]
点击复制

肺癌合并2型糖尿病患者的临床特点分析()
分享到:

《中国实用乡村医生杂志》[ISSN:1672-7185/CN:21-1502/R]

卷:
26
期数:
2019年11期
页码:
42-44
栏目:
临床研究
出版日期:
2019-11-15

文章信息/Info

Title:
Clinical Characteristics of Lung Cancer with Type 2 Diabetes Mellitus
文章编号:
 1672-7185(2019)11-0042-03 
作者:
顾冬雪 张雪云 柳立岩
作者单位:110016 沈阳,辽宁省人民医院呼吸一科
Author(s):
GU Dongxue ZHANG Xueyun LIU Liyan
(Department of the First Respiratory, Liaoning Provincial People’s Hospital, Shenyang 110016, Liaoning Province, China)
关键词:
 肺癌2型糖尿病临床特点
Keywords:
 Lung Cancer Type 2 Diabetes Mellitus Clinical Characteristics
分类号:
 R56 
DOI:
10.3969/j.issn.1672-7185.2019.11.019
文献标志码:
 A
摘要:
 目的 分析肺癌合并2型糖尿病患者的临床特点。方法 对2017年7月—2019年6月在辽宁省人民医院住院的450例肺癌患者的临床资料进行回顾性分析,所有患者依据是否患有2型糖尿病进行分组研究,比较两组患者的一般资料、凝血功能和肿瘤标记物水平。结果 合并2型糖尿病的肺癌患者(观察组)其年龄、体质量指数、糖尿病家族史与未合并2型糖尿病的肺癌患者(对照组)比较,差异均有统计学意义( P<0.05)。两组性别、吸烟史差异无统计学意义(P>0.05)。两组肺癌病理分型差异无统计学意义(P>0.05)。两组凝血酶原时间、活化部分凝血活酶时间差异有统计学意义(P<0.05),其他凝血功能指标差异无统计学意义(P>0.05)。两组癌胚抗原、神经元特异性烯醇化酶和细胞角蛋白19片段水平差异有统计学意义( P<0.05)。结论 肺癌与2型糖尿病能够相互影响,并相互促进两种疾病的发生和发展。对于高龄、高体质量指数、有糖尿病家族史的肺癌患者,要高度警惕其罹患2型糖尿病的可能。
Abstract:
Objective To analyze the clinical characteristics of lung cancer with type 2 diabetes mellitus. Methods The clinical data of 450 patients with lung cancer hospitalized in Liaoning Provincial People’s Hospital from July 2017 to June 2019 were retrospectively analyzed. All patients were divided into two groups according to whether they had type 2 diabetes mellitus or not. The general data, coagulation function and the level of tumor markers were compared between the two groups. Results There were significant differences in age, body mass index, family history of diabetes mellitus between lung cancer patients with type 2 diabetes mellitus(observation group) and those without type 2 diabetes mellitus(control group)(P<0.05). There were no significant differences in gender and smoking history between the two groups(P>0.05). There was no significant difference in pathological classification of lung cancer between the two groups(P>0.05). There were significant differences in prothrombin time and activated partial thromboplastin time between the two groups(P<0.05), but no significant differences in other coagulation function indexes(P>0.05). The levels of carcinoembryonic antigen(CEA), neuron specific enolase(NSE) and cytokeratin 19 fragment were significantly different between the two groups(P<0.05). Conclusion Lung cancer and type 2 diabetes can interact and promote the occurrence and development of the two diseases. For elderly lung cancer patients, patients with high BMI, and patients with diabetes mellitus family history, the possibility of type 2 diabetes mellitus should be highly vigilant.

参考文献/References:

[1]中华人民共和国国家卫生健康委.原发性肺癌诊疗规范(2018年版)[EB/OL].http://www.nhc.gov.cn/ewebeditor/uploadfile/2018/12/20181225162102206.docx.
[2] 高琳,叶山东.2型糖尿病合并恶性肿瘤的临床特点分析[J].中国糖尿病杂志,2015,23(10):873-876.
[3] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-7.
[4] 陈玉琴,陈刚.2型糖尿病与肺癌[J].国际呼吸杂志,2014,34(4):278-281.
[5]王许,李庆龙,刘颖.2型糖尿病与肺癌发生的相关性分析[J].癌症进展,2016,14(7):693-695.
[6] 蒋永源.2型糖尿病患者罹患肺癌的危险因素分析[D].西安:第三军医大学,2015:13-20.
[7]子英,夏忠胜,巫翟,等.合并2型糖尿病的结直肠癌患者的临床特点及其意义[J].新医学,2015,45(8):550-554.
[8] 王艳霞,孙国庆,冯立东.评价非小细胞肺癌患者血清C EA、C Y F RA21-1和N SE检测的临床诊断价值[ J].河南外科学杂志,2014,20(1):4-6.
[9] 刘品力,陈燕玲,王春城,等.2型糖尿病患者凝血功能与血管病变的相关性分析[J].中国老年学杂志,2016,36(7):1615-1617.
[10] 李艳琴.2型糖尿病下肢静脉病变与凝血功能异常的关系[J].血栓与止血学,2017,23(3):468-470.

相似文献/References:

[1]肖立国.全身麻醉与腰硬联合麻醉对肺癌根治术患者认知功能影响的比较[J].中国实用乡村医生杂志,2019,26(02):69.[doi:10.3969/j.issn.1672-7185.2019.02.028 ]
 XIAO Liguo.Comparison of Effects between General Anesthesia and Combined Spinal Epidural Anesthesia on Cognitive Function in Lung Cancer Patients Undergoing Radical Resection[J].Chinese Practical Journal of Rural Doctor,2019,26(11):69.[doi:10.3969/j.issn.1672-7185.2019.02.028 ]
[2]葛宏雷.支气管袖状肺叶切除术治疗中心型肺癌的效果分析[J].中国实用乡村医生杂志,2019,26(01):64.[doi:10.3969/j.issn.1672-7185.2019.01.027 ]
 GE Honglei.Effect of Bronchial Sleeve Lobectomy in the Treatment of Central Lung Cancer[J].Chinese Practical Journal of Rural Doctor,2019,26(11):64.[doi:10.3969/j.issn.1672-7185.2019.01.027 ]
[3]张霞.术前吉西他滨联合顺铂辅助化疗对Ⅲ期非小细胞肺癌患者手术及预后的影响[J].中国实用乡村医生杂志,2019,26(01):66.[doi:10.3969/j.issn.1672-7185.2019.01.028 ]
 ZHANG Xia.Effect of Preoperative Gemcitabine Combined with Cisplatin Adjuvant Chemotherapy on the Operation and Prognosis for Patients with Stage Ⅲ Non-small Cell Lung Cancer[J].Chinese Practical Journal of Rural Doctor,2019,26(11):66.[doi:10.3969/j.issn.1672-7185.2019.01.028 ]
[4]邹开春 张素英 薛新春 李磊 山凤莲 姜鲁宁 蒋胜华.经气道内超声引导针吸活检术确诊同期肺癌食管癌重复癌1例报告[J].中国实用乡村医生杂志,2019,26(04):72.[doi:10.3969/j.issn.1672-7185.2019.04.023 ]
[5]阎欣 李萍 孔研 曲范杰.厄洛替尼治疗老年晚期非小细胞肺癌的临床效果[J].中国实用乡村医生杂志,2018,25(09):73.[doi:10.3969/j.issn.1672-7185.2017.09.025 ]
 YAN Xin,LI Ping,KONG Yan,et al.Clinical Effect of Erlotinib in Treatment of Advanced Non-small Cell Lung Cancer in Elderly[J].Chinese Practical Journal of Rural Doctor,2018,25(11):73.[doi:10.3969/j.issn.1672-7185.2017.09.025 ]
[6]高良莹.肺癌围手术期健康教育路径应用效果观察[J].中国实用乡村医生杂志,2018,25(08):68.[doi:10.3969/j.issn.1672-7185.2018.08.022 ]
 GAO Liangying.Observation of the Effect of Perioperative Health Education Pathway for Lung Cancer[J].Chinese Practical Journal of Rural Doctor,2018,25(11):68.[doi:10.3969/j.issn.1672-7185.2018.08.022 ]

备注/Memo

备注/Memo:
收稿日期:2019-07-04)

更新日期/Last Update: 2019-11-26